Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

86.51
Delayed Data
As of May 25
 +0.29 / +0.34%
Today’s Change
81.28
Today|||52-Week Range
123.37
-14.51%
Year-to-Date
3 Stocks the Market Loves to Hate, but You Should Love
May 25 / MotleyFool.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16
May 25 / Zacks.com - Paid Partner Content
What the Sharp Dropoff in Buybacks Says About the Market
May 24 / TheStreet.com - Paid Partner Content
Adding to a Quintet of Longs
May 25 / TheStreet.com - Paid Partner Content
20 stocks the 'smart money' is betting against
May 23 / CNNMoney.com
Gilead (GILD) Shares Spike After Exec. Board Appointment
May 25 / TheStreet.com - Paid Partner Content
Your 2016 Guide to Investing in Gilead Sciences Stock
May 23 / MotleyFool.com - Paid Partner Content
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
May 25 / MotleyFool.com - Paid Partner Content
Endonovo Therapeutics: Innovative Treatment, Catalyst Create Compelling Opportunity
May 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close86.22
Today’s open86.80
Day’s range85.70 - 87.00
Volume11,653,708
Average volume (3 months)12,041,263
Market cap$114.8B
Dividend yield2.17%
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-4.21%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)+28.71%
P/E ratio7.4
Price/Sales4.80
Price/Book6.62

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+2.85+1.87%
BIIBBiogen+6.76+2.48%
BXLTBaxalta Inc+0.71+1.58%
BAXBaxter International...-0.16-0.37%
Data as of 05/25/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$3.01
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Financial Officer &
Executive Vice President
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs